reference/25411016

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/25411016

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	77
issn	0003-4819
issueIdentifier	3
pageRange	169-77
publicationName	Annals of Internal Medicine
startingPage	169
bibliographicCitation	Devereux RB, Dahlöf B, Kjeldsen SE, Julius S, Aurup P, Beevers G, Edelman JM, de Faire U, Fyhrquist F, Helle Berg S, Ibsen H, Kristianson K, Lederballe-Pedersen O, Lindholm LH, Nieminen MS, Omvik P, Oparil S, Snapinn S, Wedel H; LIFE Study Group. Effects of losartan or atenolol in hypertensive patients without clinically evident vascular disease: a substudy of the LIFE randomized trial. Ann Intern Med. 2003 Aug 05;139(3):169–77. doi: 10.7326/0003-4819-139-3-200308050-00006. PMID: 12899584.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db834f06a06565325d7caa698c596f78 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb71168ae4d0d71cb6b1623ac7208d91 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_364894b88f1aae9b6847d8b81499dcfa http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_18f6c9e7a38a10c37faeeef1f541cd95 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_aaa9c2f94802401a2781faafdbed4601 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0f658fe92148f1fba2768147da42e786 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d6753dbdd59236ed07f4e53cf2156270 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_071b6ee5d4f87818ea0c018bfb88dd68 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8a706cd3f0f8541f7cbc1f021e36a4a3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3de082956c2a62694aabc5002eda9442 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e5422533559474d34ec02d8397392740 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58b94e3885f188061d905723846fd1ad http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_29ac787fa7ab28f01c2d6b9d639a152f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20ebb78cacdb67f1606514cb6bc0e7ac http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f9e0ad725a8b467af6040005e03425f1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b965639c24e01c0ac75fc97771731ce4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_301de199edce2756c2e7104e18ceafe6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c81b2b601676b3086f10e33fa30351c8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54f077cf050cb5a42ad2debc1af37e0a
date	2003-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/12899584 https://doi.org/10.7326/0003-4819-139-3-200308050-00006
isPartOf	https://portal.issn.org/resource/ISSN/0003-4819 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/596
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Effects of Losartan or Atenolol in Hypertensive Patients without Clinically Evident Vascular Disease: A Substudy of the LIFE Randomized Trial
discusses	http://id.nlm.nih.gov/mesh/M0001900 http://id.nlm.nih.gov/mesh/M0539833 http://id.nlm.nih.gov/mesh/M0029400 http://id.nlm.nih.gov/mesh/M0001456 http://id.nlm.nih.gov/mesh/M0000495
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D002318Q000517 http://id.nlm.nih.gov/mesh/D006973Q000188 http://id.nlm.nih.gov/mesh/D017379Q000150 http://id.nlm.nih.gov/mesh/D019808Q000627 http://id.nlm.nih.gov/mesh/D000959Q000627 http://id.nlm.nih.gov/mesh/D001262Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D057911 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D006973Q000150 http://id.nlm.nih.gov/mesh/D000319Q000627 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D004562 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D000368
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9585 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2249 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3961 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6635 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10602 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID172198 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7440 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10017

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128585206 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128961263

Total number of triples: 71.